About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

AZD6765 for Treatment Resistant Depression

NCT00491686·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

21–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of Depression
Inadequate response to an adequate course of antidepressants

You may not be if

Psychiatric disorder other than depression
Pregnancy or lactation
Current diagnosis of cancer

The record

StatusCompleted

PhasePhase 2

Taking part34

StartedJul 2007

UpdatedJan 21, 2011

Conditions

Where5

Research Site
Glendale, California, United States
Research Site
Hartford, Connecticut, United States
Research Site
New Haven, Connecticut, United States

Clareo Health | AZD6765 for Treatment Resistant Depression